Bicara Therapeutics Inc. Common Stock (BCAX) short interest & short volume · 10.3M shares short
Bicara Therapeutics Inc. Common Stock official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.
What changed
BCAX short interest fell 3.7% to 10.3M shares in the Oct 15, 2026 report (11.5 days to cover). Daily short volume averaged 44.9% of volume over the last 20 sessions, down from 48.0% the 20 sessions before, the 3rd percentile of its own 20-day averages since Sep 23, 2025.
Short interest
Official, twice monthly · settled Oct 15, 2026
- Shares short
- 10.3M
- prior 10.7M
- % of float
- —
- no float on file
- Days to cover
- 11.5
- avg vol 893K
- Change vs prior report
- -3.7%
Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.
Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026
Daily short volume
Share of each day's volume sold short · FINRA Reg SHO
- Latest (Nov 2)
- 19.3%
- 199K of 1.0M
- 20-day average
- 44.9%
- prior 48.0%
- Percentile vs own history
- 3rd
- 233 periods since 2025
Loading prices…
Source: FINRA Reg SHO daily short sale volume · Latest Nov 2, 2026
Short squeeze score (model)
Price since settlement: -49.1%
Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.
BCAX's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr
Market-wide: most shorted stocks, biggest changes and unusual short volume · BCAX overview
| Date | Short | Total | Short % of volume |
|---|---|---|---|
| 2026-11-02 | 199,240 | 1,030,541 | 19.3% |
| 2026-10-30 | 412,985 | 1,579,743 | 26.1% |
| 2026-10-29 | 442,294 | 1,451,815 | 30.5% |
| 2026-10-28 | 1,996,558 | 7,064,302 | 28.3% |
| 2026-10-27 | 109,185 | 239,077 | 45.7% |
| 2026-10-26 | 188,111 | 491,114 | 38.3% |
| 2026-10-23 | 146,639 | 267,294 | 54.9% |
| 2026-10-22 | 166,474 | 340,237 | 48.9% |
| 2026-10-21 | 148,900 | 241,411 | 61.7% |
| 2026-10-20 | 65,002 | 165,481 | 39.3% |
Healthcare peers with similar quant ratings
BCAX is rated 1.83 of 5 among 532 rated Healthcare stocks (Lician quant rating, Nov 4, 2026). How the rating works
- QDEL short interest1.86 · Sell · stock
- CTMX short interest1.85 · Sell · stock
- PRME short interest1.85 · Sell · stock
- SIGA short interest1.84 · Sell · stock
- BDTX short interest1.82 · Sell · stock
- CUE short interest1.82 · Sell · stock
- VYGR short interest1.81 · Sell · stock
- RVMD short interest1.80 · Sell
BCAX short interest FAQ
What is BCAX's short interest?
Bicara Therapeutics Inc. Common Stock (BCAX) had 10.3M shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report.
How many days to cover does BCAX have?
11.5 days: 10.3M shares short divided by an average daily volume of 893K for the Oct 15, 2026 period.
Is BCAX short interest rising or falling?
BCAX short interest fell (-3.7%) from 10.7M to 10.3M shares in the Oct 15, 2026 report.
Is BCAX a short squeeze candidate?
Lician's squeeze watch scores BCAX 25 out of 100 (low) from the Oct 15, 2026 report: days to cover 25/25, change in short interest vs prior report 0/15, price change since settlement date 0/20. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.
What share of BCAX daily volume is sold short?
44.9% on average over the last 20 sessions to Nov 2, 2026 (FINRA Reg SHO daily short volume; the 3rd percentile of its own 20-day averages). Short volume counts market makers' same-day short sales, so it is not short interest.
What was BCAX's latest FINRA short volume?
On Nov 2, 2026, cached FINRA short volume for Bicara Therapeutics Inc. Common Stock (BCAX) was 199,240 shares, 19.3% of 1,030,541 total volume.
How many BCAX short-volume sessions are listed on this page?
This page lists 10 cached FINRA short-volume sessions for Bicara Therapeutics Inc. Common Stock (BCAX), from Oct 20, 2026 through Nov 2, 2026.
How did BCAX short volume percent change from the prior cached session?
Cached FINRA short volume for Bicara Therapeutics Inc. Common Stock (BCAX) moved from 26.1% on Oct 30, 2026 to 19.3% on Nov 2, 2026, down 6.8 percentage points.
Not investment advice. Figures as filed or reported, not a live feed.